Zobrazeno 1 - 10
of 52
pro vyhledávání: '"R. Deman"'
Autor:
Guy Brusselle, R. Deman, Georges Van Maele, Geert Verleden, Bénédicte Demeyere, Anja Delporte, Ingel K. Demedts, Jerina Boelens, Geert Claeys, Ellen Deschepper, Katia M.C. Verhamme, Elizaveta Padalko, Guy Joos, Veerle Ringoet, Hans Slabbynck, Johny Verschakelen, Paul Jordens, Christine VanderStichele
Publikováno v:
Thorax, 68(4), 322-329. BMJ Publishing Group
Background Patients with severe asthma are at increased risk of exacerbations and lower respiratory tract infections (LRTI). Severe asthma is heterogeneous, encompassing eosinophilic and non-eosinophilic (mainly neutrophilic) phenotypes. Patients wit
Publikováno v:
The international journal of audiology
In this short communication, we evaluate the place-pitch relation of a newly designed, deeply inserted, cochlear implant electrode. The insertion depths ranged from 471 degrees to 662 degrees. Pitch perception was measured in eight subjects with mono
Autor:
F. Verhelst, P. Bertrand, J. Verschuere, S. Marien, L. Roex, Johan Vansteenkiste, A. Verstraete, J. Vandebroek, R. Deman, H. Ulrichts, T. De Beukelaar, Maurits Demedts, J. Bockaert, P. De Muynck, W. Van Kerckhoven
Publikováno v:
Lung Cancer. 13:295-303
The efficacy and toxicity of a regimen adding ifosfamide to the more classical cisplatin-vindesine combination was studied in patients with advanced non-small cell lung cancer. Sixty-four good performance patients with inoperable stage III or stage I
Autor:
Geert Verleden, Ingel K. Demedts, Guy Brusselle, Christine Vander Stichele, R. Deman, Veerle Ringoet, Georges Van Maele, Hans Slabbynck, Ellen Deschepper, Guy Joos, Paul Jordens
Publikováno v:
C22. ASTHMA THERAPY.
Autor:
B. Van Holsbeeck, Stefaan Gryspeerdt, M. Herman, F. Baert, R. Deman, M. Baekelandt, Philippe Lefere, G. Ghillebert, L. Rutgeerts
Publikováno v:
European radiology. 15(6)
The objective of this study was to evaluate dietary fecal tagging (FT) as a cleansing method prior to CT colonography (CTC) in patients with incomplete conventional colonoscopy (CC). After written informed consent was obtained, 24 patients had standa
Autor:
Kurt Vandeurzen, Christophe Dooms, Jean Vandebroek, Paul Van den Brande, Koen Deschepper, Lionel Bosquée, Jean Pierre D'Odemont, Dany Galdermans, Nancy Dams, R. Deman, Alain Delobbe, Wim Van Kerckhoven, Kristiaan Nackaerts, Luc Siemons, Johan Vansteenkiste
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 40(2)
Background: We previously reported that treatment of patients with symptomatic advanced non-small cell lung cancer with single agent Gemcitabine (GEM) resulted in a superior clinical-benefit response rate (RR) compared to cisplatin-based combination
Autor:
Jörg Trojan, Thomas Berg, M. Schuchmann, H. Wedemeyer, R. deMan, J.P. Bronowiki, Jörg Petersen, K. Rutter, Ulrich Spengler, Christoph Sarrazin, Peter Buggisch, B Fülöp, Hermann E. Wasmuth, Heinz-Hubert Feucht, Andreas Erhardt, F. van Bömmel, Katja Deterding, Bertram Wiedenmann, Jurriën G.P. Reijnders, S. Brost, Peter Ferenci, Alexandre Pariente, M. Bourlière, Dietrich Hüppe
Publikováno v:
Journal of Hepatology. 50:S337-S338
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 26(8)
We report a first case of occupational allergy to chicory (Cichorium intybus) in a vegetable wholesaler. Symptoms occurred after oral, cutaneous or inhalatory exposure. The patient also reported reactions after ingestion of botanically related endive
Publikováno v:
The American Journal of Gastroenterology. 95:3336-3337
Postmenopausal bleeding and nipple congestion heralding ovarian metastases of a primary colonic adenocarcinoma
Autor:
Jeff Sorbel, Elsa Mondou, G.M. Dusheiko, Joseph B. Quinn, J. Anderson, Georgios Germanidis, F. Rousseau, R. deMan, Patrick Marcellin, Paul Nikolaidis, E.J. Heathcote, Ira M. Jacobson
Publikováno v:
Journal of Hepatology. 50:S330
achieved RVR and of these, 77 (89.5%) had SVR. RVR rates for genotype 1 patients (53.2%) were significantly lower (86.8%) than genotype 2 and 3 (chi(2)=16.563, p=0.000). SVR rates for genotype 1 patients who had achieved RVR (90.4%) were significantl